Motif Bio plc
  • About
    • About Motif Bio
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Scientific and Commercial Team
    • Careers
  • Development Programs
    • Pipeline Overview
    • Iclaprim
    • Publications
  • Partnering
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
    • Stock Details
    • Financial Reports
    • Corporate Governance
    • AIM Investors
    • Investor FAQs
    • Investor Resources
  • Contact
Press enter to begin your search
AIM Investors

Motif Bio plc Announces Voluntary Delisting from the Nasdaq Capital Market

By Motif November 26, 2019 No Comments

Motif Bio plc Announces Voluntary Delisting from the Nasdaq Capital Market

https://www.motifbio.com/wp-content/uploads/2019/11/MTFB-Voluntary-Delisting-from-the-Nasdaq-Capital-Market-26.11.19.pdf
Get MotifBio Email Alerts Subscribe

About Us

Motif Bio is a clinical-stage biopharmaceutical company focused on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant Gram-positive bacteria, including MRSA.

Recent News

  • Voluntary delisting from the NASDAQ Capital Market

    Dec 10, 2019
  • Motif Bio plc Announces Voluntary Delisting from the Nasdaq Capital Market

    Nov 26, 2019

Navigation

  • About Motif
  • Iclaprim
  • Investors
  • News Releases
  • Contact Us

Contact Us

Motif Bio plc
201 Temple Chambers
3-7 Temple Avenue
London EC4Y 0DT
United Kingdom

Motif BioSciences Inc.
125 Park Avenue, 25th Floor
New York, NY 10017
United States
General: info@motifbio.com
Investors: ir@motifbio.com

© 2019 Motif Bio | Disclaimer & Terms of Use

  • About
    • About Motif Bio
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Scientific and Commercial Team
    • Careers
  • Development Programs
    • Pipeline Overview
    • Iclaprim
    • Publications
  • Partnering
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
    • Stock Details
    • Financial Reports
    • Corporate Governance
    • AIM Investors
    • Investor FAQs
    • Investor Resources
  • Contact
This website uses cookies to improve your experience. You can opt-out if you wish.
Accept Read More
Privacy & Cookies Policy

Privacy Overview

Privacy Overview

Non Necessary

This is an non-necessary category.

Analytics
Save & Accept